Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FORMFACTOR INCFORM · Entity 3670 | Director | September 03, 2026 | September 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FORMFACTOR INC
Report date September 03, 2026 · Filed September 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 24,426 |
Reported balance
After 2026-09-03 transaction · row 1
1 source rowRow 1 · 2026-09-03 · Sale · Disposed 2,100 · Balance 24,426 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2026 Filed Sep 4, 2026 20:51 UTC | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 2,100 | $96.10 | $201,810.21 |
DisclosureSEC source: 0001628280-26-060753 · wk-form4_1788555057.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,426 Read SEC document |
| May 15, 2026 Filed May 15, 2026 22:22 UTC | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 5,400 | $125.60 | $678,240.54 |
DisclosureSEC source: 0001628280-26-035733 · wk-form4_1778883732.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,179 Read SEC document |
| May 15, 2026 Filed May 19, 2026 23:08 UTC | FORMFACTOR INC FORM · Entity 3670 | GrantCommon Stock | 1,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-036636 · wk-form4_1779232102.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,526 F1 · date: The reporting person was granted restricted stock units ("RSUs") pursuant to a grant approved by the Board in April 2026. F2 · shares: If the reporting person ceases to provide services to the Issuer for any reason, all Restricted Stock Units that have not yet vested shall be forfeited without consideration except as provided in our Equity Grant Policy for Outside Directors and any other applicable agreements between the reporting person and Issuer. F3 · shares: RSUs vest monthly and become exercisable on the earlier of the 2027 Annual Meeting of Stockholders and May 15, 2027. Read SEC document |
| February 10, 2026 Filed Feb 11, 2026 22:45 UTC | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 2,200 | $93.70 | $206,138.90 |
DisclosureSEC source: 0001628280-26-007379 · wk-form4_1770849942.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,579 Read SEC document |
| December 02, 2025 Filed Dec 2, 2025 21:43 UTC | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 2,700 | $55.97 | $151,105.50 |
DisclosureSEC source: 0001628280-25-054803 · wk-form4_1764711835.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,779 Read SEC document |
| September 12, 2025 Filed Sep 12, 2025 23:59 UTC | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 3,600 | $30.43 | $109,530.00 |
DisclosureSEC source: 0001039399-25-000106 · wk-form4_1757721550.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,479 Read SEC document |
| May 16, 2025 Filed May 17, 2025 00:49 UTC | FORMFACTOR INC FORM · Entity 3670 | GrantCommon Stock | 6,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001039399-25-000061 · wk-form4_1747442947.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,079 F1 · date: The reporting person was granted restricted stock units ("RSUs") pursuant to a grant approved by the Board in May 2025. F2 · shares: If the reporting person ceases to provide services to the Issuer for any reason, all Restricted Stock Units that have not yet vested shall be forfeited without consideration except as provided in our Equity Grant Policy for Outside Directors and any other applicable agreements between the reporting person and Issuer. F3 · shares: RSUs vest monthly and become exercisable on the earlier of the 2026 Annual Meeting of Stockholders and May 16, 2026. Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 21:10 UTC | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 3,870 | $31.02 | $120,047.40 |
DisclosureSEC source: 0001039399-25-000027 · wk-form4_1741295436.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,551 Read SEC document |
| May 17, 2024 Filed May 21, 2024 23:18 UTC | FORMFACTOR INC FORM · Entity 3670 | GrantCommon Stock | 3,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001498143-24-000004 · wk-form4_1716333476.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,421 F1 · date: The reporting person was granted restricted stock units ("RSUs") pursuant to a grant approved by the Board in March 2024. F2 · shares: If the reporting person ceases to provide services to the Issuer for any reason, all Restricted Stock Units that have not yet vested shall be forfeited without consideration except as provided in our Equity Grant Policy for Outside Directors and any other agreements between the reporting person and Issuer, regarding award vesting and exercisability. F3 · shares: RSUs vest monthly and become exercisable on the earlier of the 2025 Annual Meeting of Stockholders and May 17, 2025 (the earliest to occur, the Settlement Date). Settlements of vested units into common stock will occur on the earlier of the Settlement Date and the date the reporting person ceases to provide service to the Issuer, and thereafter on the first market trading day if the applicable date is not a market trading day. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:29 UTC | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 4,800 | $54.24 | $260,334.72 |
DisclosureSEC source: 0001498143-24-000002 · wk-form4_1715200164.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,593 F1 · price: Price represents the weighted average sale price for the transaction reported. Price range of shares sold is $54.2201 through $54.32. Reporting person undertakes to provide upon request by the SEC staff or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: Due to an administrative error, a Form 4 filed by the Reporting Person on May 14, 2022 underreported the number of shares acquired in connection with a settlement of restricted stock units by 10 shares. Hence, the total number of shares beneficially owned by the Reporting Person reported in this column reflects the corrected number. Read SEC document |
| May 19, 2023 Filed May 31, 2023 00:34 UTC | FORMFACTOR INC FORM · Entity 3670 | GrantCommon Stock | 6,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-020194 · wf-form4_168549326478461.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,383 F1 · date: The reporting person was granted restricted stock units ("RSUs") pursuant to a grant approved by the Board in March 2023. F2 · shares: Restricted Stock Units Vest and become exercisable on May 19, 2024. Settlements of vested units into common stock will occur on the earlier of May 19, 2024 or the date the reporting person ceases to provide service to the Issuer, and thereafter on the first market trading day if the applicable date is not a market trading day. F3 · shares: If the reporting person ceases to provide services to the Issuer for any reason, all Restricted Stock Units that have not yet vested shall be forfeited without consideration except as provided in our Equity Grant Policy for Outside Directors and any other agreements between the reporting person and Issuer, regarding award vesting and exercisability. F4 · balance_after: The reported transaction involved the reporting person's receipt of a grant of 6,770 RSUs. The reporting person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 6,770 newly awarded RSUs, 4,833 RSUs previously reported in Table II, 4,833 of which vested on May 27, 2023, and 25,780 shares of common stock. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 21:03 UTC | FORMFACTOR INC FORM · Entity 3670 | GrantRestricted Stock Units · Derivative | 4,833 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001039399-22-000049 · wf-form4_165411736875858.xml · derivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,833 Underlying: Common Stock · 4,833 shares Expires not disclosed F1 · derivative.exercise_date: Restricted Stock Units Vest and become exercisable on May 27, 2023. Settlements of vested units into common stock will occur on the earlier of May 27, 2023 or the date the reporting person ceases to provide service to the Issuer, and thereafter on the first market trading day if the applicable date is not a market trading day. F2 · derivative.expiration_date: If the reporting person ceases to provide services to the Issuer for any reason, all Restricted Stock Units that have not yet vested shall be forfeited without consideration except as provided in our Equity GrantPolicy for Outside Directors and any other agreements between the reporting person and Issuer, regarding award vesting and exercisability. Read SEC document |
| May 14, 2022 Filed May 17, 2022 23:06 UTC | FORMFACTOR INC FORM · Entity 3670 | Exercise / conversionRestricted Stock Units · Derivative | 3,792 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001039399-22-000031 · wf-form4_165282877196924.xml · derivative · entry 2 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,792 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted Stock Units Vest and become exercisable on May 14, 2022. Settlements of vested units into common stock will occur on the earlier of May 14, 2022 or the date the reporting person ceases to provide service to the Issuer, and thereafter on the first market trading day if the applicable date is not a market trading day. F2 · derivative.expiration_date: If the reporting person ceases to provide services to the Issuer for any reason, all Restricted Stock Units that have not yet vested shall be forfeited without consideration except as provided in our Equity Grant Policy for Outside Directors and any other agreements between the reporting person and Issuer, regarding award vesting and exercisability. Read SEC document |
| May 14, 2022 Filed May 17, 2022 23:06 UTC | FORMFACTOR INC FORM · Entity 3670 | Exercise / conversionCommon Stock | 3,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001039399-22-000031 · wf-form4_165282877196924.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2022 Filed Feb 10, 2022 22:57 UTC | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 6,000 | $42.62 | $255,703.20 |
DisclosureSEC source: 0001039399-22-000007 · wf-form4_164453382254761.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,998 F1 · price: Price represents the weighted average sale price for the transaction reported. Price range of shares sold is $42.40 through $42.835. Reporting person undertakes to provide upon request by the SEC staff or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 09, 2022 Filed Feb 14, 2022 23:19 UTC Amendment | FORMFACTOR INC FORM · Entity 3670 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $6.93 | $0.00 |
DisclosureSEC source: 0001039399-22-000009 · wf-form4a_164488015095999.xml · derivative · entry 3 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2022-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Option exercise was inadvertently not reported on the original form 4. F3 · derivative.exercise_date: The Stock Option is granted pursuant to the Issuer's 2012 Equity Incentive Plan and vests over 3 years. Read SEC document |
| February 09, 2022 Filed Feb 14, 2022 23:19 UTC Amendment | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 6,000 | $42.62 | $255,703.20 |
DisclosureSEC source: 0001039399-22-000009 · wf-form4a_164488015095999.xml · nonDerivative · entry 2 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,988 F2 · price: Price represents the weighted average sale price for the transaction reported. Price range of shares sold is $42.40 through $42.835. Reporting person undertakes to provide upon request by the SEC staff or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 09, 2022 Filed Feb 14, 2022 23:19 UTC Amendment | FORMFACTOR INC FORM · Entity 3670 | Exercise / conversionCommon Stock | 6,000 | $6.93 | $41,580.00 |
DisclosureSEC source: 0001039399-22-000009 · wf-form4a_164488015095999.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Option exercise was inadvertently not reported on the original form 4. Read SEC document |
| November 24, 2021 Filed Nov 26, 2021 17:30 UTC | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 3,000 | $43.12 | $129,362.10 |
DisclosureSEC source: 0001039399-21-000090 · wf-form4_163794783228921.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,998 F1 · price: Price represents the weighted average sale price for the transaction reported. Price range of shares sold is $43.09 through $43.13. Reporting person undertakes to provide upon request by the SEC staff or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 17, 2021 Filed May 19, 2021 00:28 UTC | FORMFACTOR INC FORM · Entity 3670 | Exercise / conversionRestricted Stock Units · Derivative | 7,098 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001039399-21-000040 · wf-form4_162138409920650.xml · derivative · entry 2 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,098 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted Stock Units vest and became exercisable in 12 equal monthly installments with the vesting dates beginning on June 15, 2020 and ending on May 15, 2021. Settlements of vested units into common stock will occur on the earlier of May 15, 2021 or the date the reporting person ceases to provide service to the Issuer, and thereafter on the first market trading day if the applicable date is not a market trading day. F2 · derivative.expiration_date: If the reporting person ceases to provide services to the Issuer for any reason, all Restricted Stock Units that have not yet vested shall be forfeited without consideration except as provided in our Equity Grant Policy for Outside Directors and any other agreements between the reporting person and Issuer, regarding award vesting and exercisability. Read SEC document |
| May 17, 2021 Filed May 19, 2021 00:28 UTC | FORMFACTOR INC FORM · Entity 3670 | Exercise / conversionCommon Stock | 7,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001039399-21-000040 · wf-form4_162138409920650.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2021 Filed May 19, 2021 00:28 UTC | FORMFACTOR INC FORM · Entity 3670 | GrantRestricted Stock Units · Derivative | 3,792 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001039399-21-000040 · wf-form4_162138409920650.xml · derivative · entry 3 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,792 Underlying: Common Stock · 3,792 shares Expires not disclosed F3 · derivative.exercise_date: Restricted Stock Units Vest and become exercisable in 12 equal monthly installments with the vesting dates beginning on June 14, 2021 and ending on May 14, 2022. Settlements of vested units into common stock will occur on the earlier of May 14, 2022 or the date the reporting person ceases to provide service to the Issuer, and thereafter on the first market trading day if the applicable date is not a market trading day. F2 · derivative.expiration_date: If the reporting person ceases to provide services to the Issuer for any reason, all Restricted Stock Units that have not yet vested shall be forfeited without consideration except as provided in our Equity Grant Policy for Outside Directors and any other agreements between the reporting person and Issuer, regarding award vesting and exercisability. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 17:28 UTC | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 4,000 | $26.55 | $106,185.20 |
DisclosureSEC source: 0001039399-20-000057 · wf-form4_159241487413986.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,900 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: Price represents the weighted average sale price for the transaction reported. Price range of shares sold is $25.85 through $27.29. Reporting person undertakes to provide upon request by the SEC staff or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 18, 2020 Filed May 19, 2020 22:16 UTC | FORMFACTOR INC FORM · Entity 3670 | Exercise / conversionRestricted Stock Units · Derivative | 9,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001039399-20-000046 · wf-form4_158992656663244.xml · derivative · entry 2 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted Stock Units Vest and become exercisable in 12 equal monthly installments with the vesting dates beginning on June 17, 2019 and ending on May 17, 2020. Settlements of vested units into common stock will occur on the earlier of May 17, 2020 or the date the reporting person ceases to provide service to the Issuer, and thereafter on the first market trading day if the applicable date is not a market trading day. F2 · derivative.expiration_date: If the reporting person ceases to provide services to the Issuer for any reason, all Restricted Stock Units that have not yet vested shall be forfeited without consideration except as provided in our Equity Grant Policy for Outside Directors and any other agreements between the reporting person and Issuer, regarding award vesting and exercisability. Read SEC document |
| May 18, 2020 Filed May 19, 2020 22:16 UTC | FORMFACTOR INC FORM · Entity 3670 | Exercise / conversionCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001039399-20-000046 · wf-form4_158992656663244.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2020 Filed May 19, 2020 22:16 UTC | FORMFACTOR INC FORM · Entity 3670 | GrantRestricted Stock Units · Derivative | 7,098 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001039399-20-000046 · wf-form4_158992656663244.xml · derivative · entry 3 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,098 Underlying: Common Stock · 7,098 shares Expires not disclosed F3 · derivative.exercise_date: Restricted Stock Units vest and became exercisable in 12 equal monthly installments with the vesting dates beginning on June 15, 2020 and ending on May 15, 2021. Settlements of vested units into common stock will occur on the earlier of May 15, 2021 or the date the reporting person ceases to provide service to the Issuer, and thereafter on the first market trading day if the applicable date is not a market trading day. F2 · derivative.expiration_date: If the reporting person ceases to provide services to the Issuer for any reason, all Restricted Stock Units that have not yet vested shall be forfeited without consideration except as provided in our Equity Grant Policy for Outside Directors and any other agreements between the reporting person and Issuer, regarding award vesting and exercisability. Read SEC document |
| September 11, 2019 Filed Sep 12, 2019 22:20 UTC | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 1,200 | $18.19 | $21,828.00 |
DisclosureSEC source: 0001039399-19-000074 · wf-form4_156832680283979.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,900 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: Price represents the sale price for the transaction reported. Reporting person undertakes to provide upon request by the SEC staff or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 11, 2019 Filed Jun 12, 2019 20:37 UTC | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 1,200 | $15.67 | $18,807.96 |
DisclosureSEC source: 0001039399-19-000042 · wf-form4_156037181825171.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,100 F1 · price: Price represents the sale price for the transaction reported. Reporting person undertakes to provide upon request by the SEC staff or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 21, 2019 Filed May 21, 2019 19:15 UTC | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 4,500 | $15.58 | $70,103.70 |
DisclosureSEC source: 0001039399-19-000039 · wf-form4_155846609388678.xml · nonDerivative · entry 2 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,300 Read SEC document |
| May 18, 2019 Filed May 21, 2019 19:15 UTC | FORMFACTOR INC FORM · Entity 3670 | Exercise / conversionRestricted Stock Units · Derivative | 9,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001039399-19-000039 · wf-form4_155846609388678.xml · derivative · entry 4 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Restricted Stock Units Vest and become exercisable in 12 equal monthly installments with the vesting dates beginning on June 18, 2018 and ending on May 18, 2019. Settlements of vested units into common stock will occur on the earlier of May 18, 2019 or the date the reporting person ceases to provide service to the Issuer, and thereafter on the first market trading day if the applicable date is not a market trading day. F2 · derivative.expiration_date: If the reporting person ceases to provide services to the Issuer for any reason, all Restricted Stock Units that have not yet vested shall be forfeited without consideration except as provided in our Equity Grant Policy for Outside Directors and any other agreements between the reporting person and Issuer, regarding award vesting and exercisability. Read SEC document |
| May 18, 2019 Filed May 21, 2019 19:15 UTC | FORMFACTOR INC FORM · Entity 3670 | Exercise / conversionCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001039399-19-000039 · wf-form4_155846609388678.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2019 Filed May 21, 2019 19:15 UTC | FORMFACTOR INC FORM · Entity 3670 | GrantRestricted Stock Units · Derivative | 9,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001039399-19-000039 · wf-form4_155846609388678.xml · derivative · entry 3 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires not disclosed F1 · derivative.exercise_date: Restricted Stock Units Vest and become exercisable in 12 equal monthly installments with the vesting dates beginning on June 17, 2019 and ending on May 17, 2020. Settlements of vested units into common stock will occur on the earlier of May 17, 2020 or the date the reporting person ceases to provide service to the Issuer, and thereafter on the first market trading day if the applicable date is not a market trading day. F2 · derivative.expiration_date: If the reporting person ceases to provide services to the Issuer for any reason, all Restricted Stock Units that have not yet vested shall be forfeited without consideration except as provided in our Equity Grant Policy for Outside Directors and any other agreements between the reporting person and Issuer, regarding award vesting and exercisability. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 17:09 UTC | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 1,200 | $15.42 | $18,504.00 |
DisclosureSEC source: 0001039399-19-000012 · wf-form4_155258333598823.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,800 F1 · price: Price represents the sale price for the transaction reported. Reporting person undertakes to provide upon request by the SEC staff or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:45 UTC | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 7,000 | $15.50 | $108,522.40 |
DisclosureSEC source: 0001039399-19-000006 · wf-form4_155019149269876.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 F1 · price: Price represents the weighted average sale price for the transaction reported. Price range of shares sold is $15.45 through $15.57. Reporting person undertakes to provide upon request by the SEC staff or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 05, 2018 Filed Aug 7, 2018 21:48 UTC | FORMFACTOR INC FORM · Entity 3670 | Exercise / conversionRestricted Stock Units · Derivative | 9,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001039399-18-000074 · wf-form4_153367847869739.xml · derivative · entry 2 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Price Not Applicable. F2 · derivative.exercise_date: Restricted Stock Units Vest and become exercisable in 36 equal monthly installments with the vesting dates beginning on September 5, 2015 and ending on August 5, 2018. Settlements of vested units into common stock will occur on the earlier of August 5, 2018 or the date the reporting person ceases to provide service to the Issuer, and thereafter on the first market trading day if the applicable date is not a market trading day. F2 · derivative.expiration_date: Restricted Stock Units Vest and become exercisable in 36 equal monthly installments with the vesting dates beginning on September 5, 2015 and ending on August 5, 2018. Settlements of vested units into common stock will occur on the earlier of August 5, 2018 or the date the reporting person ceases to provide service to the Issuer, and thereafter on the first market trading day if the applicable date is not a market trading day. Read SEC document |
| August 05, 2018 Filed Aug 7, 2018 21:48 UTC | FORMFACTOR INC FORM · Entity 3670 | Exercise / conversionCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001039399-18-000074 · wf-form4_153367847869739.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock units released were settled in shares of common stock and were immediately cancelled upon settlement. Read SEC document |
| May 26, 2018 Filed May 30, 2018 23:54 UTC | FORMFACTOR INC FORM · Entity 3670 | Exercise / conversionRestricted Stock Units · Derivative | 9,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001039399-18-000063 · wf-form4_152772440272691.xml · derivative · entry 2 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted Stock Units Vest and become exercisable in 12 equal monthly installments with the vesting dates beginning on June 26, 2017 and ending on May 26, 2018. Settlements of vested units into common stock will occur on the earlier of May 26, 2018 or the date the reporting person ceases to provide service to the Issuer, or thereafter, on the first market trading day. F2 · derivative.expiration_date: If the reporting person ceases to provide services to the Issuer for any reason, all Restricted Stock Units that have not yet vested shall be forfeited without consideration except as provided in our Equity Grant Policy for Outside Directors and any other agreements between the reporting person and Issuer, regarding award vesting and exercisability. Read SEC document |
| May 26, 2018 Filed May 30, 2018 23:54 UTC | FORMFACTOR INC FORM · Entity 3670 | Exercise / conversionCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001039399-18-000063 · wf-form4_152772440272691.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2018 Filed May 22, 2018 22:42 UTC | FORMFACTOR INC FORM · Entity 3670 | GrantRestricted Stock Units · Derivative | 9,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001039399-18-000044 · wf-form4_152702892533316.xml · derivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires not disclosed F1 · derivative.exercise_date: Restricted Stock Units Vest and become exercisable in 12 equal monthly installments with the vesting dates beginning on June 18, 2018 and ending on May 18, 2019. Settlements of vested units into common stock will occur on the earlier of May 18, 2019 or the date the reporting person ceases to provide service to the Issuer, and thereafter on the first market trading day if the applicable date is not a market trading day. F2 · derivative.expiration_date: If the reporting person ceases to provide services to the Issuer for any reason, all Restricted Stock Units that have not yet vested shall be forfeited without consideration except as provided in our Equity Grant Policy for Outside Directors and any other agreements between the reporting person and Issuer, regarding award vesting and exercisability. Read SEC document |
| May 14, 2018 Filed May 15, 2018 18:13 UTC | FORMFACTOR INC FORM · Entity 3670 | SaleCommon Stock | 8,000 | $13.22 | $105,768.80 |
DisclosureSEC source: 0001039399-18-000032 · wf-form4_152640794446142.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 F1 · price: Price represents the weighted average sale price for the transaction reported. Price range of shares sold is $13.15 through $13.30. Reporting person undertakes to provide upon request by the SEC staff or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 26, 2017 Filed Jun 6, 2017 22:55 UTC | FORMFACTOR INC FORM · Entity 3670 | GrantRestricted Stock Units · Derivative | 9,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950103-17-005527 · dp77126_4-steven.xml · derivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires not disclosed F1 · derivative.exercise_date: Restricted Stock Units Vest and become exercisable in 12 equal monthly installments with the vesting dates beginning on June 26, 2017 and ending on May 26, 2018. Settlements of vested units into common stock will occur on the earlier of May 26, 2018 and the date the reporting person ceases to provide service to the Issuer, or thereafter, on the first market trading day in an open trading window under Issuer's insider trading policy if the applicable date is not a market trading day in an open trading window. F2 · derivative.expiration_date: If the reporting person ceases to provide services to the Issuer for any reason, all Restricted Stock Units that have not yet vested shall be forfeited without consideration except as provided in our Equity Grant Policy for Outside Directors and any other agreements between the reporting person and Issuer, regarding award vesting and exercisability. Read SEC document |
| May 20, 2017 Filed May 23, 2017 20:18 UTC | FORMFACTOR INC FORM · Entity 3670 | Exercise / conversionRestricted Stock Units · Derivative | 9,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950103-17-004827 · dp76395_4-steven.xml · derivative · entry 2 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted Stock Units Vest and become exercisable in 12 equal monthly installments with the vesting dates beginning on June 20, 2016 and ending on May 20, 2017. Settlements of vested units into common stock will occur on the earlier of May 20, 2017 or the date the reporting person ceases to provide service to the Issuer. F2 · derivative.expiration_date: The restricted stock units released were settled in shares of common stock and were immediately cancelled upon settlement. Read SEC document |
| May 20, 2017 Filed May 23, 2017 20:18 UTC | FORMFACTOR INC FORM · Entity 3670 | Exercise / conversionCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-17-004827 · dp76395_4-steven.xml · nonDerivative · entry 1 STEVEN-WAISS KELLEY · CIK 0001498143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.